Status:
COMPLETED
A Prospective Observational Study of the Clinical Performance of Zarin in Madagascar
Lead Sponsor:
FHI 360
Collaborating Sponsors:
Bill and Melinda Gates Foundation
Marie Stopes International
Conditions:
Long-term and Permanent Contraceptive Methods
Eligibility:
FEMALE
Brief Summary
This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Mada...
Detailed Description
This one-year observational study will monitor the contraceptive effectiveness, safety and acceptability of Zarin during the first year of use after the method has been approved for public use in Mada...
Eligibility Criteria
Inclusion
- be a participant of the MSM service evaluation and continue using Zarin at 3 months
- agree at the time of Zarin insertion to be contacted regarding an opportunity to participate in more research related to the implant
Exclusion
- \-
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
621 Patients enrolled
Trial Details
Trial ID
NCT01200576
Start Date
October 1 2010
End Date
March 1 2012
Last Update
March 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marie Stopes Madagascar Mobile Outreach Sites and Static Clinics
Madagascar, Madagascar